{
    "title": "Pfizer pouring COVID profits into cancer battle, CEO Bourla says",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12073775/Pfizer-pouring-COVID-profits-cancer-battle-CEO-Bourla-says.html",
    "date": "2023-05-11",
    "keywords": [
        "treatment",
        "bourla",
        "pfizer",
        "covid",
        "vaccine",
        "cancer",
        "revenue",
        "company",
        "erman",
        "inc",
        "covid19",
        "battle",
        "purchase",
        "seagen",
        "year",
        "pipeline",
        "drug",
        "deal",
        "disease",
        "government",
        "executive",
        "albert",
        "event",
        "technology",
        "effort",
        "moonshot",
        "record",
        "forefront",
        "response",
        "surge",
        "midst",
        "fall",
        "product",
        "competition",
        "result",
        "blockbuster",
        "companys",
        "development",
        "string",
        "complex",
        "maker",
        "prevention",
        "buyout",
        "colitis",
        "developer",
        "arena",
        "blood",
        "focus",
        "sickle",
        "cell",
        "drugmaker",
        "partner",
        "biontech",
        "world",
        "health",
        "emergency",
        "thursday",
        "cost",
        "round",
        "booster",
        "market",
        "price",
        "shot",
        "dose",
        "reporting",
        "york",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}